Reuters.comAlzheimer's drug study yields positive results, say makers Eisai and BiogenSep 29, 2022Julie Steenhuysen, Deena Beasley & Rocky SwiftBy Julie Steenhuysen, Deena Beasley & Rocky Swiftmore_vert
Alzheimer's Research UKNew hope as Alzheimer's drug slows memory decline in phase 3 trialSep 28, 2022more_vert
Reuters.comBiogen shares soar on landmark Alzheimer's data, lift rivalsSep 28, 2022Natalie Grover & Manas MishraBy Natalie Grover & Manas Mishramore_vert
The GuardianSuccess of experimental Alzheimer’s drug hailed as ‘historic moment’Sep 28, 2022Hannah DevlinBy Hannah Devlinmore_vert
The New York TimesAlzheimer's Drug Slows Cognitive Decline in Key Study (Published 2022)Sep 27, 2022Pam Belluck & Rebecca RobbinsBy Pam Belluck & Rebecca Robbinsmore_vert
BBC.comAlzheimer's-slowing drug labelled historicSep 28, 2022James GallagherBy James Gallaghermore_vert
New ScientistAlzheimer's drug results are promising – but not a major breakthroughSep 28, 2022Clare WilsonBy Clare Wilsonmore_vert
NBC NewsAlzheimer's drug slowed progression of the disease in Phase 3 trialSep 28, 2022Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert
Reuters.comEisai's trial success raises hope for Alzheimer's preventionSep 30, 2022Julie SteenhuysenBy Julie Steenhuysenmore_vert